DRACP00333 |
Z6 |
KWWKKAAKAAKKAAKAAKKWA |
21 |
Synthetic |
DRACP00334 |
Pardaxin |
GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE |
33 |
Red Sea Mosessole |
DRACP00335 |
Peptide-1 |
IELLQARGGCX |
11 |
Synthetic |
DRACP00336 |
Peptide-2 |
IELLQARGGCXGGRRRRRRRR |
21 |
Synthetic |
DRACP00337 |
Peptide-3 |
RRRRRRRRGGCX |
12 |
Synthetic |
DRACP00338 |
Lytic |
KLlLKlLkkLLKlLKKK |
17 |
Interleukin-4 receptor a (IL-4Ra) chain |
DRACP00339 |
IL-4Rα-lytic peptide |
KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK |
33 |
Interleukin-4 receptor a (IL-4Ra) chain |
DRACP00340 |
MAC1/2 |
AFGMALKLLKKVL |
13 |
Synthetic |
DRACP00341 |
MAC1/26 |
GFGMAXKLLKKVL |
13 |
Synthetic |
DRACP00342 |
MAC1/25 |
GFGMALKXLKKVL |
13 |
Synthetic |
DRACP00343 |
MAC1/24 |
GFGMALKLXKKVL |
13 |
Synthetic |
DRACP00344 |
MAC1 |
GFGMALKLLKKVL |
13 |
Macropins and their analogs |
DRACP00345 |
MAC1/1 |
gfgmalkllkkvl |
13 |
Synthetic |
DRACP00346 |
MAC1/16 |
GFGMALKLlKKVL |
13 |
Synthetic |
DRACP00347 |
MAC1/19 |
GFGmALKLLKKVL |
13 |
Synthetic |
DRACP00348 |
MAC1/4 |
GFGMaLKLLKKVL |
13 |
Synthetic |
DRACP00349 |
MAC1/6 |
GfGMALKLLKKVL |
13 |
Synthetic |
DRACP00350 |
MAC1/20 |
GFGMALXLLXXVL |
13 |
Synthetic |
DRACP00351 |
MAC1/21 |
GFGMALRLLRRVL |
13 |
Synthetic |
DRACP00352 |
MAC1/10 |
GFkMALKLLKKVL |
13 |
Synthetic |
DRACP00353 |
MAC1/9 |
GFKMALKLLKKVL |
13 |
Synthetic |
DRACP00354 |
HAL-2/24 |
GKFMSLLKHILK |
12 |
Synthetic |
DRACP00355 |
HAL-1/19 |
GKWKKILGHLIR |
12 |
Synthetic |
DRACP00356 |
HAL-1/21 |
GKWKKILGKLIR |
12 |
Synthetic |
DRACP00357 |
HAL-2/1 |
GKWKSLLKHILK |
12 |
Synthetic |
DRACP00358 |
HAL-2/11 |
GKWLSLLKHILK |
12 |
Synthetic |
DRACP00359 |
HAL-2/2 |
GKWMKLLKHILK |
12 |
Synthetic |
DRACP00360 |
HAL-1/15 |
GMWSKLLGHLLR |
12 |
Synthetic |
DRACP00361 |
MAC2 |
GTGLPMSERRKIMLMMR |
17 |
Synthetic |
DRACP00362 |
HAL-1/17 |
KMWSKILGHLIR |
12 |
Synthetic |